GENE ONLINE|News &
Opinion
Blog

Feature
Abbott’s Homemade Coronavirus Test bags FDA’s Emergency Authorization
2020-03-19
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Hunt for mRNA-based Coronavirus Vaccine Intensifies after BioNTech’s Alliance with Fosun Pharma, Pfizer
2020-03-17
Taiwan’s Action Strategies Provide Great Model to Fight Coronavirus
2020-03-16
Thermo Fisher’s Coronavirus Detection Kit Gets FDA Emergency Authorization
2020-03-14
Prediction of the COVID-19 Outbreak in South Korea and Italy
2020-03-14
New Study Suggests How Children Might be Persistently Spreading Coronavirus
2020-03-13
Roche Gets Emergency FDA Approval for Fastest COVID-19 Diagnostic Test Yet
2020-03-13
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
COVID-19 Victims on Remdesivir Treatment Hopeful after First US Patient Recovers
2020-03-12
Vir Biotechnology Stocks Raise after COVID-19 Partnership with Biogen
2020-03-12
WHO Officially Labels COVID-19 Outbreak a Pandemic
2020-03-11
Rapid Diagnosis: Academia Sinica’s New COVID-19 Detection Kit Augurs well for Combating the Epidemic
2020-03-10
First Potential Treatment for COVID-19 Greenlighted by Korean Authorities
2020-03-08
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
1 54 55 56 57 58 60
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top